Abstract
The present invention describes the identification, production and testing of a recombinant ZIKV antigen which allows the development of specific serological tests for those infected with the virus. Unlike tests available on the market, the present antigen detected specifically antibodies produced in ZIKV-infected patients even from people which were infected previously by other flaviviru…
